Governance Roche Holding AG

ROP

CH1499059983

Pharmaceuticals

End-of-day quote Swiss Exchange Other stock markets 2026-06-05			5-day change	1st Jan Change
327.10 ^CHF	+0.77%		-0.67%	-0.34%

07:32pm	Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial	RE
Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE

Executive Committee: Roche Holding AG

Manager

Positions heldSince

Thomas Schinecker

51 year

Chief Executive Officer

2023-03-14

Claudia Boeckstiegel

62 year

General Counsel

2020-03-31

Wafaa Mamilli

58 year

Chief Tech/Sci/R&D Officer

2025-02-09

Levi Garraway

58 year

Chief Tech/Sci/R&D Officer

2022-12-31

Pascale Schmidt

53 year

Compliance Officer

2019-12-31

Alan Hippe

59 year

Director of Finance/CFO

2011-06-05

Cristina Wilbur

59 year

Human Resources Officer

Bruno Eschli

Investor Relations Contact

2014-07-31

Per-Olof Attinger

66 year

Corporate Secretary

Gabriella Gentile

Chief Operating Officer

2025-09-30

Composition of the Board of Directors: Roche Holding AG

Director

CommitteesSince

Severin Schwan

59 year

Chairman

2023-03-14

André Hoffmann

68 year

Governance Committee	1995-12-31
Nominating Committee	1995-12-31
Compensation Committee Chair	1995-12-31
Compensation Committee	1995-12-31
Governance Committee Chair	1995-12-31

Anita Hauser

57 year

Compensation Committee	2017-03-13
Nominating Committee	2017-03-13

Joerg Duschmale

42 year

Audit Committee	2020-03-16
Compensation Committee Chair	2020-03-16

Ulf Mark Schneider

61 year

Audit Committee	2023-02-28
Governance Committee	2014-09-30

Jemilah Mahmood

67 year

Governance Committee

2022-02-28

Akiko Iwasaki

56 year

Governance Committee

2023-02-28

Patrick Frost

58 year

Audit Committee Chair

2020-03-16

Richard P. Lifton

73 year

Director/Board Member	2015-03-02
Independent Dir/Board Member	2015-03-02

Latest Appointments: Roche Holding AG

Mar. 29

Champions Oncology, Inc. Board of Directors Changes

More news

Former Officers and Directors: Roche Holding AG

Insider

Positions held

SinceUntil

Christoph Franz

Chairman	2014-02-28	2023-03-14
Independent Dir/Board Member	2014-02-28	2023-03-14

Nicolas Dunant

Public Communications Contact

2019-01-31

2022-04-30

William Pao

Corporate Officer/Principal

2014-04-30

2022-03-17

Paul Bulcke

Director/Board Member	2011-06-05	2021-12-31
Independent Dir/Board Member	2011-09-05	2012-03-14

Gottlieb A. Keller

General Counsel	2010-01-12	2020-03-30
Corporate Secretary	2007-12-31	2020-03-30

John Bell

Director/Board Member	2009-09-16	2020-03-16
Independent Dir/Board Member	2011-03-31	2011-09-11
Corporate Officer/Principal	2000-12-31	2009-09-16

Andreas Oeri

Director/Board Member	2010-01-12	2020-03-16
Independent Dir/Board Member	2011-09-05	2020-03-16
Corporate Officer/Principal	1995-12-31	2010-01-12

Stephan Feldhaus

Public Communications Contact

2010-09-07

2019-09-29

Peter Voser

Director/Board Member	2011-01-31	2019-06-29
Independent Dir/Board Member	2011-09-05	2012-03-14

John Reed

Corporate Officer/Principal

2013-04-01

2018-04-01

Roland Diggelmann

Corporate Officer/Principal

2011-12-31

2017-12-31

Pius Baschera

Director/Board Member	2010-01-12	2017-03-30
Independent Dir/Board Member	2011-09-05	2011-09-11

DeAnne Shirley Julius

Director/Board Member	2010-01-12	2016-02-29
Independent Dir/Board Member	2011-09-05	2016-02-29
Corporate Officer/Principal	2001-12-31	2010-01-12

Beatrice Weder di Mauro

Director/Board Member	2010-01-12	2016-02-29
Independent Dir/Board Member	2011-07-28	2011-09-11

Silvia Ayyoubi

Human Resources Officer

2010-01-12

2015-12-30

Bernard Poussot

Director/Board Member	2015-03-02	-
Independent Dir/Board Member	2015-03-02	-

Hyam Levitsky

Corporate Officer/Principal

2011-07-31

2015-01-31

Michael Varney

Corporate Officer/Principal

2014-12-31

Richard Scheller

Corporate Officer/Principal

2008-12-31

2014-12-30

William Burns

Director/Board Member	2010-02-28	2014-03-03
Independent Dir/Board Member	2010-02-28	2012-03-14

Franz Humer

Chairman

2011-09-05

2014-03-03

Lodewijk J. R. de Vink

Director/Board Member	2010-01-12	2013-03-04
Independent Dir/Board Member	2011-04-10	2011-09-11
Corporate Officer/Principal	2003-12-31	2010-01-12

Bruno Gehrig

Director/Board Member	2003-12-31	2013-03-04
Independent Dir/Board Member	2003-12-31	2012-03-14

Jean-Jacques Garaud

Corporate Officer/Principal

2006-12-31

2012-06-29

Klaus Gustav Strein

Corporate Officer/Principal

2011-09-13

Erich Hunziker

Director/Board Member	2011-01-17	2011-01-17
Chief Tech/Sci/R&D Officer	2010-01-12	2011-03-30
Director of Finance/CFO	2001-09-30	2011-03-30

Wolfgang Ruttenstorfer

Director/Board Member	2010-01-12	2010-12-13
Independent Dir/Board Member	2006-12-31	2010-12-31

Walter Frey

Director/Board Member	2010-01-12	2010-12-13
Independent Dir/Board Member	2000-12-31	2010-12-31
Corporate Officer/Principal	2000-12-31	2010-01-12

David Goldstein

Corporate Officer/Principal

1993-12-31

2010-12-31

Peter Brabeck-Letmathe

Director/Board Member

2010-02-28

Arthur Levinson

Director/Board Member	2010-02-28	-
Independent Dir/Board Member	2011-04-25	2011-09-11

Eduard Enrico Holdener

Corporate Officer/Principal

1994-12-31

2006-12-31

Michael Burgess

Corporate Officer/Principal

2011-10-23

Rolf Hänggi

Director/Board Member

2005-12-31

Dirk W. Kirsten

Corporate Officer/Principal

2001-12-31

2003-12-31

Domenico Scala

Corporate Officer/Principal	1994-12-31	1999-12-31
Treasurer	1999-12-31	2002-12-31

Henri-Paul Meier

Investor Relations Contact	2011-09-08	-
Public Communications Contact	2002-03-14	-

Horst Teltschik

Director/Board Member	2010-01-12	-
Corporate Officer/Principal	2001-12-31	2010-01-12

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

1977-12-31

Vincent Charlon

Corporate Officer/Principal

1989-12-31

1997-12-31

Rolf Schläpfer

Public Communications Contact

1996-12-31

Unni Hjelmaas

Corporate Officer/Principal

1996-12-31

Gerard Farmer

General Counsel

1988-12-31

Pierre Jaccoud

Corporate Secretary

1987-12-31

Marc Salzberg

Corporate Officer/Principal

Wing-Kai Chan

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Markus Hosang

Corporate Officer/Principal

Daniel O'Day

Corporate Officer/Principal

Eva Losert

Public Communications Contact

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Melanie Wolf

Public Communications Contact

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

2010-09-07

Ann Moravick

Corporate Officer/Principal

Peter Johann

Sales & Marketing

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Andreas Emmenegger

Corporate Officer/Principal

Dámaso Molero

Corporate Officer/Principal

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

2013-01-30

Jean-Pierre Obrecht

Corporate Officer/Principal

Tim George

Sales & Marketing

Ken A. Brameld

Corporate Officer/Principal

Alexander Zehnder

Corporate Officer/Principal

Stefan Ryser

Human Resources Officer

Robert Salcedo

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Age distribution of managers

Parity Men Women

Male	15
Female	9

Of which Executive Committee

Male	5
Female	5

Of which Directors

Male	8
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,249

Sector

Pharmaceuticals

Calendar

Jul. 23 - Earnings release - Q2 2026

More about the company